1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing
    Meeting Abstract

    Nafa, K.; Zehir, A.; Mitchell, T.; Borsu, L.; Singer, S.; Tap, W.; Oultache, A.; Ladanyi, M.; Hechtman, J.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Papillary renal cell carcinoma (PRCC),type 1: A single institutional study of 199 cases addressing classification, clinicopathologic features and treatment outcome
    Meeting Abstract

    Murugan, P.; Chen, Y. B.; Sirintrapun, S.; Al-Ahmadie, H.; Gopalan, A.; Fine, S.; Imnadze, M.; Assel, M.; Russo, P.; Tickoo, S.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Papillary renal cell carcinoma (PRCC),type 1: A single institutional study of 199 cases addressing classification, clinicopathologic features and treatment outcome
    Meeting Abstract

    Murugan, P.; Chen, Y. B.; Sirintrapun, S.; Al-Ahmadie, H.; Gopalan, A.; Fine, S.; Imnadze, M.; Assel, M.; Russo, P.; Tickoo, S.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • MED12 somatic mutations in fibroadenomas and phyllodes tumors of the breast
    Meeting Abstract

    Murray, M.; Piscuoglio, S.; Marchio, C.; Loo, F.; Akram, M.; Weigelt, B.; Brogi, E.; Reis-Filho, J.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • MED12 somatic mutations in fibroadenomas and phyllodes tumors of the breast
    Meeting Abstract

    Murray, M.; Piscuoglio, S.; Marchio, C.; Loo, F.; Akram, M.; Weigelt, B.; Brogi, E.; Reis-Filho, J.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing analysis of angiosarcomas reveals common MAPK pathway alterations and MYC amplifications
    Meeting Abstract

    Murali, R.; Chandramohan, R.; Moller, I.; Berger, M.; Huberman, K.; Viale, A.; Pirun, M.; Socci, N.; Bouvier, N.; Hillen, U.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing analysis of angiosarcomas reveals common MAPK pathway alterations and MYC amplifications
    Meeting Abstract

    Murali, R.; Chandramohan, R.; Moller, I.; Berger, M.; Huberman, K.; Viale, A.; Pirun, M.; Socci, N.; Bouvier, N.; Hillen, U.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A.; Stiff, P. J.; Gianni, A. M.; Carella, A. M.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Pre-analytic and analytic validation of automated PTEN immunohistochemistry to detect PTEN loss in prostate cancer
    Meeting Abstract

    Morals, C.; Gopalan, A.; Hicks, J.; Reuter, V.; Scher, H.; De Marzo, A.; Lotan, T.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Pre-analytic and analytic validation of automated PTEN immunohistochemistry to detect PTEN loss in prostate cancer
    Meeting Abstract

    Morais, C.; Gopalan, A.; Hicks, J.; Reuter, V.; Scher, H.; De Marzo, A.; Lotan, T.
    Modern Pathology (2015)

    Fulltext@MSK | Save